Diagnostics, monitoring and treatment of arterial hypertension in children

   The review presents material on the current relevance of AH in children. The prevalence of AH in overweight and obese children aged 6-18 years is 27–47 %, while secondary arterial hypertension remains dominant, especially in children younger than 5 years. AH is a major risk factor for atherosclerosis and cardiovascular disease in adults. The onset of these diseases may occur in childhood or adolescence. The use of modern methods to monitor and control BP is crucial for improving the management of AH and preventing damage to target organs. Twenty-four-hour BP measurements are an important tool in determining the prognosis and treatment of children with AH. AH in children can be classified as primary or essential if there is no identifiable cause, or as secondary AH when it arises from a specific cause. The incidence of primary arterial hypertension increases with age, whereas secondary arterial hypertension predominates in early childhood. The secondary causes of AH also depend on the age of the patient. Thus 34-79 % of patients with secondary forms of arterial hypertension have renal parenchymal disease and impaired renal structure. Signs of AH include headache, visual disturbances, dizziness and nosebleeds. Dyspnoea on exercise, facial paralysis and seizures indicate target organ damage. In children with obesity, diabetes, renal insufficiency, aortic coarctation/repaired coarctation and those receiving medication causing AH, BP should be measured at every visit to the physician. Therapeutic lifestyle changes are an early therapy in the treatment of AH in children. IAPs, BCAAs, BRAs and thiazide diuretics are the most effective drugs for AH in children.

1. Savenkova N. D. Renal Arterial Hypertension in children and adolescents : Causes, Classification, diagnosis. Russian Bulletin of Perinatology and Pediatrics 2017; 62 (4): 43–48. (In Russ.) doi: 10.21508/1027-4065-2017-62-4-43-48

2. McNiece K. L., Poffenbarger T. S., Turner J. L., Franco K. D., Sorof J. M., Portman R. J. Prevalence of hypertension and prehypertension among adolescents. J Pediatr 2007; 150 (6): 640–644. doi: 10.1016/j.jpeds.2007.01.052

3. Flechtner-Mors M., Neuhauser H., Reinehr T., Roost H. P., Wiegand S., Siegfried W. et al. APV initiative and the BMBF Competence Network Obesity. Am J Cardiol 2015; 115: 1587–1594. doi: 10.1016/j.amjcard.2015.02.063

4. Agapitov L. I., Cherepnina I. V. Diagnostics and treatment of arterial hypertension in children and adolescents, overview of new clinical guidelines of the American Academy of Pediatrics. Ros Vestn Perinatol i Pediatr 2019; 64: (4): 114–127 (in Russ.). doi: 10.21508/1027–4065–2019–64–4–114–127

5. Diagnosis, treatment and prevention of arterial hypertension in children and adolescents. Russian recommendations (second revision). Cardiovascular therapy and prevention 2009; (4S1): 3–32. (in Russ.) URL: https://www.volgmed.ru/uploads/files/2013-4/18538-diagnostika_lechenie_i_profilaktika_arterialnoj_gipertenzii_u_detej_i_podrostkov_vtoroj_peresmotr.pdf

6. Flynn J. T., Kaelber D. C., Baker-Smith C. M. et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017; 140–20171904. doi: 10.1542/peds.2017-1904

7. McNiece K. L., Poffenbarger T. S., Turner J. L., Franco K. D., Sorof J. M., Portman R. J. Prevalence of hypertension and prehypertension among adolescents. J Pediatr 2007; 150 (6): 640–644. doi: 10.1016/j.jpeds.2007.01.052

8. Baracco R., Kapur G., Mattoo T., Jain A., Valentini R., Ahmed M. et al. Prediction of primary vs secondary hypertension in children. J Clin Hypertens (Greenwich) 2012; 14 (5): 316–321. doi: 10.1111/j.1751-7176.2012.00603.x

9. Gupta-Malhotra M., Banker A., Shete S., Hashmi S. S., Tyson J. E., Barratt M. S. et al. Essential hypertension vs. secondary hypertension among children. Am J Hypertens 2015; 28 (1): 73–80. doi: 10.1093/ajh/hpu083

10. Flynn J. T. Hypertension in the neonatal period. Curr Opin Pediatr 2012; 24 (2): 197–204. doi: 10.1097/MOP.0b013e32834f8329

11. Korovina N. A., Tvorogova T. M., Kuznetsova O. A. Primary arterial hypertension in pediatric practice. RMJ 2007; 1: 2–9. (in Russ.)

12. Kaukov I. G., Smirnov A. V., Shabunin M. A. et al. Rarely diseases in the practice of «adult» nephrologist: the state associated with hypokaliemia. Communication II. Liddle syndrome. Nephrology (Saint-Petersburg) 2009; 13 (1): 98–106. (In Russ.) URL: https://cyberleninka.ru/article/n/redkie-zabolevaniya-v-praktike-vzroslogo-nefrologa-sostoyaniya-assotsiirovannye-s-gipokaliemiey-soobschenie-i-gomeostaz-kaliya

13. Yukina M. Yu., Troshina E. A., Bel'tsevich D. G., Platonova N. M. Secondary (Endocrine) Hypertension: Lecture. Almanac of Clinical Medicine. 2016; 44 (4): 501–512. (In Russ.) doi: 10.18786/2072-0505-2016-44-4-501-512

14. Gupta-Malhotra M., Banker A., Shete S., Hashmi S. S., Tyson J. E., Barratt M. S. et al. Essential hypertension vs. secondary hypertension among children. Am J Hypertens 2015; 28 (1): 73–80. doi: 10.1093/ajh/hpu083

15. Falkner B., DeLoach S., Kei-й S. W., Gidding S. S. High risk blood pressure and obesity increase the risk for left ventricular hypertrophy in African-American adolescents. J Pediatr 2013; 162 (1): 94–100. doi: 10.1016/j.jpeds.2012.06.009

16. Hansen M. L., Gunn P. W., Kaelber D. C. Underdiagnosis of hypertension in children and adolescents. JAMA 2007; 298 (8): 874–879. doi: 10.1001/jama.298.8.874

17. Litwin M. Feber J. Origins of Primary Hypertension in Children. 2020; 76: 1400–1409. doi: 10.1161/HYPERTENSIONAHA.120.14586

18. Wühl E., Witte K., Soergel M., Mehls O., Schaefer F. German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children:normalized reference values and role of body dimensions. J Hypertens 2002; 20: 1995–2007

19. Lurbe E., Redon J. The role of ambulatory blood pressure monitoring in diagnosis of hypertension and evaluation of target organ damage. In: Flynn J. T., Ingelfinger J. R., Portman R. J., eds. Pediatric hypertension. Humana Press, 2011; 517–528

20. Salice P., Ardissino G., Zanchetti A., Ghiglia S. Age-dependent differences in office (OBP) vs ambulatory blood pressure monitoring (ABPM) in hypertensive children and adolescents. J Hypertens 2010; 28: 423–424. doi: 10.1097/01.hjh.0000379493.32284.c8

21. Leontieva I. V., Agapitov L. I. 24-hour blood pressure monitoring in the differential diagnosis of arterial hypertension in adolescents. Russian Journal of Cardiology 2000; 4 (24): 18–23. (In Russ.)

22. Urbina E. M., Lande M. B., Hooper S. R., Daniels S. R. Target Organ Abnormalities in Pediatric Hypertension. J Pediatrics 2018; 202: 14–22. doi: 10.1016/j.jpeds.2018.07.026

23. Karimdzhanov I. A., Iskanova G. K., Israilova N. A. Chronic kidney disease in children: problems of arterial hypertension. Nephrology (Saint-Petersburg) 2019; 23 (5): 47–55. (In Russ.) doi: 10.24884/1561-6274-2019-23-5-47-55

24. Killian L. , Simpson J. M., Savis A., Rawlins D., Sinha M. D. Electrocardiography is a poor screening test to detect left ventricular hypertrophy in children. Arch Dis Child 2010; 95 (10): 832–836. doi: 10.1136/adc.2009.168377

25. Brady T. M. Obesity-Related Hypertension in Children. Frontiers in Pediatrics 2017; 5: 197. doi: 10.3389/fped.2017.00197

26. Khoury M., Urbina E., Cardiac and Vascular Target Organ Damage in Pediatric Hypertension. Front Pediatr 2018; 24 (6): 148. doi: 10.3389/fped.2018.00148

27. Savenkova N. D., Grigoreva O. P. Pediatric problems of stratification of the severity of stages, cardiovascular complications and renal forecast of chronic kidney disease by NKF-K / DOQI (2002) and KDIGO (2012) classifications. Nephrology (Saint-Petersburg) 2021; 25 (3): 9–19. (In Russ.) doi: 10.36485/1561-6274-2021-25-3-9-19

28. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555–576. doi: 10.1542/peds.2004-2345

29. Lurbe E., Cifkova R., Cruickshank J. K. et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2017; 27: 1719–1742. doi: 10.1016/j.anpedi.2010.04.001

30. Yuan W. L., Kakinami L., Gray-Donald K., Czernichow S., Lambert M., Paradis G. Influence of dairy product consumption on children’s blood pressure: results from the QUALITY cohort. J Acad Nutr Diet 2013; 113 (7): 936–941. doi: 10.1016/j.jand.2013.03.010

31. Moore L. L., Bradlee M. L., Singer M. R., Qureshi M. M., Buendia J. R., Daniels S. R. Dietary approaches to stop hypertension (DASH) eating pattern and risk of elevated blood pressure in adolescent girls. Br J Nutr2012; 108 (9): 1678–1685. DOI: 10.1017/S000711451100715X.

32. Yang Q., Zhang Z., Kuklina E. V., Fang J., Ayala C., Hong Y., et al. Sodium intake and blood pressure among US children and adolescents. Pediatrics 2013; 130: 611–619. doi: 10.1007/s11906-013-0382-z

33. He F. J., MacGregor G. A. Importance of salt in determining blood pressure in children: meta-analysis of controlled trials. Hypertension 2006; 48: 861–869. doi: 10.1161/01.HYP.0000245672.27270.4a

34. Farpour-Lambert N. J., Aggoun Y., Marchand L. M., Martin X. E., Herrmann F. R., Beghetti M. Physical activity reduces systemic blood pressure and improves early markers of atherosclerosis in prepubertal obese children. J Am Coll Cardiol 2009; 54: 2396–2406. doi: 10.1016/j.jacc.2009.08.030

35. Wuhl E., Mehls O., Schaefer F., ESCAPE Trial Group. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 2004; 66: 768–776. doi: 10.1111/j.1523-1755.2004.00802.x

36. Swinford R. D., Portman R. J. Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease. Adv Chronic Kidney Dis 2004; 11 (2): 143–161. doi: 10.1053/j.arrt.2004.02.001

37. Halbach S., Flynn J. Treatment of hypertension in children with chronic kidney disease. Curr Hypertension Rep 2015; 17 (1): 503. doi: 10.1007/s11906-014-0503-3

38. Tran A. Н., Urbina E. М. Hypertension in children. Curr Opin Cardiol July 2020; 35 (4): 376–380. doi: 10.1097/HCO.0000000000000744

39. Hadtstein C., Schaefer F. Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol (Berlin, Germany) 2008; 23 (3): 363–371. doi: 10.1007/s00467-007-0643-7

40. Zuber S. M. Hypertension in pheochromocytoma: Characteristics and treatment. SM. Zuber, V. Kantorovich, K. Pacak. Endocrinology Metabolism Clinics of North America 2011; 40 (2): 295–311. doi: 10.1016/j.ecl.2011.02.002

41. Ferguson M. A., Flynn J. T. Rational use of anthypertensive medications in children. Pediatr Nephrol 2013; 29: 979–988. doi: 10.1007/s00467-013-2510-z

42. Wells T., Frame V., Soffer B. et al. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol 2002; 42 (8): 870–880. doi: 10.1177/009127002401102786

43. Ellis D., Vats A., Moritz M. L., Reitz S., Grosso M. J., Janosky J. E. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria. J Pediatr 2003; 143: 89–97. doi: 10.1016/S0022-3476(03)00279-8

44. Von Vigier R. O., Franscini L. M. D., Bianda N. D., Pfister R., CasaultaAebischer C., Bianchetti M. G. Antihypertensive efficacy of amlodipine in children with chronic kidney diseases. J Hum Hypertens 2001; 15: 387–391

45. Аzovskiy D. K., Lekmanov А. U., Shadchnev А. P. The use of β-blockers in children in ICU – results of the interactive survey, a brief overview and own opinion.Messenger of Anesthesiology and Resuscitation 2020; 17 (3): 53–60. (In Russ.)

46. Avner E. D. et al eds. Chronic Kidney Disease. Pediatric Nephrology. 7th ed. Springer Reference, New York 2016; 2061–2064

47. Blowey D. L. Diuretics in the treatment of hypertension. Pediatr Nephrol (Berlin, Germany) 2016; 31 (12): 2223–2233. doi: 10.1007/s00467-016-3334-4

48. Arguedas J. A., Perez M. I., Wright J. M. Treatment blood pressure targets for hypertension. Cochrane Database Syst Rev 2009; CD004349. doi: 10.1002/14651858.CD004349.pub2

49. Mancia G., Fagard R., Narkiewicz K., Redo´n J., Zanchetti A., Bo¨hm M. et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281–1357. doi: 10.1093/eurheartj/eht151

50. Adelman R. D., Coppo R., Dillon M. J. The emergency management of severe hypertension. Pediatr Nephrol 2000; 14: 422–427. doi: 10.1007/s004670050787